Filter posts

CNBC Commentary: Hedge funds, 'reverse trolls' crushing biopharma innovation

Patents are the lifeblood of medical innovation. They are the cornerstone that enables companies to …

Big Oil Asks Congress to Do What the Courts Denied

“This contention is meritless.” Doesn’t “withstand scrutiny.” “Ignores salient facts.” That was the judgment of …

House Judiciary Committee’s Patent Reform Bill is in Need of Reform, Says BIO

PRESS RELEASE WASHINGTON, D.C. (Friday, April 15, 2011) – Biotechnology Industry Organization (BIO) President and CEO …